Weight Loss Supplements Recalled for Containing Banned Medications
A weight loss supplement has been recalled after testing found that it contained unapproved medications.
A laboratory analysis by the Food and Drug Administration (FDA) found that UltraZX contained sibutramine and phenolphthalein, which are controlled substances that are not approved for any use in the U.S.
Sibutramine was removed from the market in October 2012 because it is known to substantially increase blood pressure and pulse rate. Studies have indicated that phenolphthalein presents a cancer risk.
UltraXZ Labs and the FDA have not received any reports of adverse events related to the supplements. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Adverse reactions or quality problems experienced with the use of this product should be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
The supplements are packaged in bottles of 30 300mg capsules and were distributed from September 2014 to February 2015.
Consumers and distributors that have the recalled supplements should stop using or selling it and return it to UltraZx Labs.
Consumers with questions regarding this recall can contact UltraZx Labs, L.L.C. at (305) 904-9393.